Reprogramming immune response with capsid-optimized AAV6 vectors for immunotherapy of cancer

Keyphrases

• Capsid 100%
• Immune Response 100%
• Cancer Immunotherapy 100%
• AAV Serotypes 100%
• Serotype 6 100%
• Specific T Cells 25%
• Ovalbumin 16%
• Prostatic Acid Phosphatase 16%
• Adenovirus 8%
• Tumor Growth 8%
• Anticancer Immune Response 8%
• Tumor Antigen 8%
• T Cell Response 8%
• Virus Serotype 8%
• Peripheral Blood 8%
• Intramuscular Administration 8%
• T Cell Clone 8%
• Specific mutation 8%
• Negative Control 8%
• Prostate Cancer Cell Lines 8%
• Stably Expressing 8%
• Bone Marrow-derived Dendritic Cells 8%
• Transduction Efficiency 8%
• Subcutaneous Tumor 8%
• Mouse Prostate 8%
• Strongest Activations 8%
• Mouse Bone Marrow 8%
• Potential Clinical Applications 8%
• Ovalbumin Antigen 8%
• Tumor Inhibition 8%

Immunology and Microbiology

• Adeno-Associated Virus 100%
• Capsid 100%
• Immune Response 100%
• Serotype 100%
• Immunotherapy 100%
• T Cell 33%
• Wild Type 25%
• In Vitro 16%
• Phosphatase 16%
• Cell Clone 8%
• Prostate Cancer Cell Line 8%
• Bone Marrow Derived Dendritic Cell 8%
• Adeno Associated Virus 8%
• Tumor Antigen 8%

Biochemistry, Genetics and Molecular Biology

• Capsid 100%
• Reprogramming 100%
• Immune Response 100%
• Serotype 100%
• T Cell 33%
• Wild Type 25%
• Ovalbumin 25%
• Animal Models 16%
• Prostatic Acid Phosphatase 16%
• Tumor Progression 16%
• Anticancer 8%
• Cancer Cell 8%
• Adeno Associated Virus 8%
• Cell Clone 8%
• Dendritic Cell 8%
• Tumor Antigen 8%